Month: April 2026

Targeted Synergistic Therapy for Bone and Brain Disorders Using Hydrogel Microneedles Loaded with Exosomes

Summary: This study presents a novel hydrogel microneedle system engineered for controlled release of exosomes. The platform enables targeted, minimally invasive delivery with synergistic therapeutic effects. In diabetic wound models, the exosome-loaded microneedles reversed macrophage dysfunction and accelerated diabetic foot ulcer healing. The technology holds broad potential for regenerative applications in both hard and soft tissues.

Key Highlights:

• Hydrogel microneedles provide sustained, localized exosome delivery
• Reversed macrophage dysfunction and improved DFU healing
• Minimally invasive platform with strong translational potential
• Dual application for bone regeneration and neurological conditions

Read full open-access article

Keywords: hydrogel microneedles, exosome therapy, DFU regeneration

Electrochemical Modulation of Host-Microbe Dynamics in Wound Healing

Summary: This review examines the growing field of bioelectric and electrochemical therapies in wound care. Electrical fields and electrochemical modulation can directly influence bacterial behavior, disrupt biofilms, promote beneficial microbial communities, and enhance host immune responses. The authors discuss current devices, mechanisms of action, and potential applications for chronic wounds, including diabetic foot ulcers. This approach represents a promising adjunct to traditional wound care by targeting the complex host-microbe interface.

Key Highlights:

• Electrical stimulation affects both host cells and wound pathogens
• Potential to reduce biofilms and pathogenic load
• Supports angiogenesis and tissue regeneration
• Emerging as a complementary strategy in advanced wound management

Read full open-access review

Keywords: electrochemical wound healing, bioelectric therapy, wound microbiome

C-Reactive Protein-to-Albumin Ratio Improves Prediction of 6-Month Major Adverse Limb Events in Patients with Diabetic Foot Ulcers

Summary: This retrospective study evaluated the prognostic value of the C-reactive protein-to-albumin ratio (CAR) in patients with diabetic foot ulcers (DFU). CAR, a readily available inflammatory biomarker, demonstrated strong independent predictive power for 6-month major adverse limb events (MALE), including major amputation and revascularization. Adding CAR to traditional risk models significantly improved discrimination and reclassification. The authors conclude that CAR is a simple, inexpensive tool that can help clinicians better stratify risk and guide intensified interventions in high-risk DFU patients.

Key Highlights:

• CAR independently predicts 6-month MALE in DFU patients
• Improves model performance when added to conventional risk factors
• Low-cost, routinely available biomarker from standard labs
• Useful for early risk stratification and personalized care

Read full open-access article

Keywords: CRP albumin ratio, DFU prognosis, major adverse limb events

Facility-Level Variation in Major Leg Amputation Among Veterans With Newly Diagnosed Diabetic Foot Ulcers

Summary: This large retrospective cohort study analyzed 86,094 Veterans (mean age 73) newly diagnosed with diabetic foot ulcers across 140 VA facilities from 2016–2021. Within one year, 3.8% underwent major leg amputation. After adjusting for patient comorbidities and social drivers of health, there was significant facility-level variation: the median odds ratio (MOR) for major amputation was 1.85 — meaning the odds were 1.85 times higher at one random facility compared to another for an otherwise similar patient. Facility variation in 1-year mortality was much smaller (MOR 1.16). The findings suggest that differences in DFU-specific care (offloading, vascular evaluation, multidisciplinary management, timely intervention) are major drivers of amputation risk and represent important targets for quality improvement.

Key Highlights:

• 3.8% major amputation rate within 1 year of new DFU diagnosis
• Facility-level median odds ratio of 1.85 for amputation (wide range 0.29–3.53)
• Variation in amputation far exceeded variation in mortality, pointing to modifiable care differences
• Authors: Hiroyuki Suzuki, MD, MSCI, et al. (JAMA Network Open, 2025)

Read full article (JAMA Network Open)

Keywords: VA DFU amputation, facility variation amputation, Hiroyuki Suzuki

Amputation Risk in Veterans with DFUs: What’s Driving Differences in Care and Outcomes

Summary: Recent research highlights two major drivers of amputation risk in Veterans with diabetic foot ulcers (DFUs). First, developing a DFU is the strongest independent predictor of lower-extremity amputation — increasing risk nearly 10-fold. Second, a large JAMA Network Open study of over 86,000 Veterans found significant facility-level variation across VA centers: the odds of major leg amputation within one year were 1.85 times higher between two randomly selected facilities for an otherwise average patient. While mortality rates were relatively consistent, amputation rates varied widely (facility odds ratios ranging from 0.29 to 3.53), suggesting differences in care delivery, rather than patient factors alone, play a critical role.

Key Highlights:

• DFU development increases amputation risk nearly 10-fold in Veterans
• Significant VA facility-level variation in amputation rates (MOR 1.85) despite similar patient populations
• Variation in care processes (early intervention, offloading, vascular assessment, multidisciplinary coordination) likely drives outcome differences
• Emphasizes need for standardized, high-quality DFU protocols across all facilities
• Source: Podimetrics analysis of recent VA studies

Read full LinkedIn post

Keywords: veterans DFU amputation, VA facility variation, limb salvage veterans

Rome Health Wound Care Center Earns National Honor

Summary: Rome Health’s Wound Care Center has been named a **Center of Distinction** by Healogics, placing it in the top 10% of nearly 600 eligible wound care centers nationwide. The recognition is based on exceptional clinical outcomes, including high healing rates and patient satisfaction. The center provides advanced wound care using evidence-based protocols and a multidisciplinary team approach.

Key Highlights:

• Top 10% nationally for clinical outcomes
• Strong performance in healing rates and patient experience
• Multidisciplinary team delivering advanced wound care

Read full announcement

Keywords: healogics center of distinction, wound care center outcomes

Synergistic Effect of Octenidine Gel and Hydrogel Dressing in the Treatment of Venous Leg Ulcers

Summary: This study investigated the combination of octenidine gel (antiseptic) with a hydrogel dressing versus standard care in patients with venous leg ulcers. The synergistic approach resulted in faster wound closure, greater reduction in bacterial load, improved granulation tissue formation, and higher complete healing rates. The treatment was safe and well-tolerated, suggesting it as a valuable option for managing colonized or infected venous ulcers while maintaining a moist healing environment.

Key Highlights:

• Significant improvement in healing speed and bacterial control
• Combines antimicrobial action with optimal moisture balance
• Effective and easy-to-use strategy for hard-to-heal venous leg ulcers

Read full open-access article

Keywords: octenidine gel, venous leg ulcer, hydrogel dressing

Minimally Invasive Procedure Confers Amputation-Free Survival in ‘No Option’ CLTI

Summary: A new real-world study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) meeting demonstrated strong outcomes using a minimally invasive procedure in patients with “no-option” chronic limb-threatening ischemia (CLTI). Participants were Rutherford class 5 or 6 with non-healing ischemic ulcers who had exhausted conventional revascularization options. The procedure resulted in high rates of limb salvage and amputation-free survival, offering hope for this extremely high-risk population where traditional therapies often fail.

Key Highlights:

• Targeted “no-option” CLTI patients with advanced ischemic ulcers
• High amputation-free survival in a challenging, real-world cohort
• Minimally invasive approach expands treatment options beyond traditional bypass or endovascular techniques
• Emphasizes the importance of continued innovation in advanced wound care and limb preservation

Read full article

Keywords: CLTI, no option CLTI, limb salvage, ischemic ulcer

Pod Patrol Podcast – Latest Episodes

Summary: Pod Patrol is a popular podcast hosted by Dr. Jeff Dikis featuring in-depth conversations with leading podiatric surgeons, residency directors, and experts. Recent episodes cover topics including cavus foot correction, flatfoot management, minimally invasive surgery (MIS), first-year practice challenges, 3D printing in foot & ankle surgery, and more. Excellent resource for residents, early-career surgeons, and anyone wanting practical surgical pearls and career insights.

Browse all episodes

Keywords: podiatry podcast, foot and ankle surgery, Pod Patrol

Fundamentals of Surgical Wound Care – May 2026

Summary: The Society of Tissue Viability is hosting a half-day virtual course on May 13, 2026 (12:30–3:45 pm) aimed at nurses, ODPs, and other clinicians involved in surgical wound care. The program covers wound healing phases, closure techniques, early recognition of complications (infection, dehiscence, seroma), dressing selection, and evidence-based wound packing. Ideal for both new and experienced staff working in hospital, community, or primary care settings.

Key Highlights:

• Practical guidance on surgical wound assessment and management
• Focus on complication prevention and early intervention
• Includes industry presentations and real-world case discussions
• 3 hours of participatory learning for NMC revalidation

Register / View full details

Keywords: surgical wound care, tissue viability

The Last Straw: Healthcare Facilities, Risk Management Organizations & Insurance Companies Need to Revolt Over US Pressure Injury Policy

Summary: Dr. Caroline Fife strongly criticizes current US pressure injury policy, particularly the NQF Serious Reportable Events (SRE) list and Joint Commission alignment. She argues that classifying most Stage 3 and 4 pressure injuries (and unstageable/DTIs) as “never events” ignores medical reality in critically ill patients. With the broadened 2016 staging definitions, many minor ulcers are now labeled Stage 3, fueling lawsuits and massive financial burdens on hospitals. She urges facilities, risk managers, and insurers to organize and advocate for evidence-based policy changes.

Key Highlights:

• Stage 3+ pressure injuries are now often treated as sentinel events regardless of preventability
• Policy fails to account for medically unavoidable ulcers in unstable/critically ill patients
• Calls for unified pushback from healthcare organizations and insurers
• Author: Caroline Fife, MD

Read full blog post

Keywords: pressure injury policy, Caroline Fife, never events

Diabetic Foot Ulcers: Offloading, Surgery, and Beyond

Summary: At SAWC Spring 2026, Dr. Paul Kim and Dr. Johanna-Marie Richey delivered a practical, high-yield session on DFU management. They emphasized moving beyond simple wound closure to address underlying biomechanical abnormalities, perfusion, infection, and patient-specific factors. Key themes included thorough biomechanical evaluation (gait, deformities, joint ROM, weight-bearing imaging), distinguishing sagittal vs. shear forces, prioritizing non-operative offloading, and using surgery selectively to correct deformity and redistribute pressure. Minor amputations should be viewed as part of a limb-preservation strategy focused on function and preventing major amputation.

Key Highlights:

• Biomechanics is a primary driver of DFU development and recurrence
• Non-operative offloading remains first-line; surgery is reserved for correctable deformities
• Flexor tenotomy, metatarsal osteotomies, and Achilles lengthening discussed as targeted options
• Goal: stable, functional residual limb with low reulceration risk
• Authors/Speakers: Paul Kim, DPM, MS & Johanna-Marie Richey, DPM

Read full article

Keywords: DFU offloading, diabetic foot surgery, biomechanical assessment, Paul Kim DPM

Skin Substitutes in Wound Care: Powerful Tools or Growing Controversy?

Summary: In a candid conversation, Dr. John Steinberg and Dr. Ben Pearl discuss the current state of skin substitutes (also known as Cellular and/or Tissue-Based Products – CTPs). They emphasize that these advanced skin replacement grafts are highly effective tools for hard-to-heal diabetic foot ulcers (DFUs) and venous leg ulcers when standard of care fails. However, they also raise strong concerns about dramatic price inflation, rebate/kickback practices, and the risk that widespread abuse could lead to restricted access or payer backlash that harms legitimate patient care.

Key Highlights:

• Skin substitutes can significantly accelerate healing and help prevent amputations in chronic, non-healing wounds
• Strong clinical evidence supports their use in appropriate patients after adequate debridement, offloading, and vascular optimization
• Major concern: Some products are billed at extremely high prices (e.g., tens of thousands of dollars) with questionable added value
• Warning that unethical pricing and rebate practices may trigger severe reimbursement restrictions, limiting access for patients who truly benefit
• Call for responsible use, transparent pricing, and focus on proven clinical outcomes

Watch the full discussion (YouTube Short)

Clinical Takeaway: Skin substitutes remain a valuable advanced therapy in modern wound care when used judiciously. The challenge for the field is to preserve access to these effective tools while addressing pricing and utilization issues that threaten their long-term viability.

Keywords: skin substitutes, CTPs wound care, diabetic foot ulcer grafting, skin replacement therapy, John Steinberg

From Glucose to Limb Salvage: New Therapeutic Frontiers to Redefine Outcomes in Diabetic Foot Disease

Summary: This forward-looking review in *Diabetes Care* emphasizes that while glycemic control remains foundational, new therapeutic frontiers are needed to address the persistent high amputation rates in diabetic foot disease. Highlighted areas include advanced wound biologics, stem cell and platelet-derived therapies, neuromodulation for perfusion and pain, smart offloading technologies, and personalized medicine approaches. The authors call for integrated multidisciplinary care models that combine metabolic optimization with these innovative tools to shift outcomes from amputation to durable limb salvage.

Key Highlights:

• Beyond glucose control: focus on perfusion, infection, and regenerative therapies
• Emerging role of biologics, neuromodulation, and sensor-based offloading
• Urgent need for better prevention and limb-preservation pathways

Read full article

Keywords: limb salvage DFU, new therapies diabetic foot

Horn-Shaped Perforator Flaps for Plantar Reconstruction in Diabetic Foot Ulcers

Summary: This review evaluates the use of horn-shaped perforator flaps for reconstructing plantar defects after debridement of diabetic foot ulcers. The technique provides like-with-like tissue (sensate, glabrous skin) with reliable blood supply from perforators, resulting in durable weight-bearing surfaces, reduced shear forces, and lower ulcer recurrence compared to skin grafts or free flaps. The authors discuss patient selection, surgical pearls, and outcomes in high-risk diabetic populations. It represents an important reconstructive option in limb salvage algorithms for deep plantar wounds.

Key Highlights:

• Horn-shaped design preserves sensation and provides robust plantar coverage
• Lower recurrence rates versus traditional grafting methods
• Useful in selected DFU cases after thorough debridement and vascular optimization

Read full open-access review

Keywords: perforator flap plantar, diabetic foot reconstruction, limb salvage flap

Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus and Metabolic Syndrome

Summary: This comprehensive review examines the impact of targeted nutrition on the efficacy of orthobiologic treatments (PRP, stem cells, bone marrow concentrate) in patients with type 2 diabetes and metabolic syndrome. Hyperglycemia and chronic inflammation impair regenerative cell function; specific interventions such as flaxseed oil (1000 mg/day) have shown DFU size reduction and improved insulin sensitivity in trials. The authors discuss omega-3 fatty acids, antioxidants, vitamin D, and Mediterranean-style diets to optimize stem cell quality, reduce oxidative stress, and enhance healing. Practical guidance is provided for integrating nutrition into multidisciplinary limb-preservation and regenerative wound care programs.

Key Highlights:

• Nutrition modulates orthobiologic efficacy in diabetic patients
• Flaxseed oil supplementation linked to smaller DFUs and better metabolic control
• Focus on anti-inflammatory and antioxidant strategies
• Authors: Multiple (MDPI IJMS team)

Read full open-access review

Keywords: nutritional interventions DFU, orthobiologics diabetes, flaxseed oil wound healing

Editorial: In vivo applications of nanozymes

Summary: This editorial discusses the expanding in vivo use of nanozymes—nanomaterials with enzyme-mimicking activities—for wound healing, with a strong focus on diabetic foot ulcer (DFU) therapy. Nanozymes address multiple barriers in chronic wounds: reactive oxygen species (ROS) scavenging (catalase/peroxidase-like activity), antibacterial effects, and promotion of angiogenesis and tissue regeneration. The piece reviews recent studies on nanozyme design for improved biocompatibility, targeted delivery, and multifunctionality. It emphasizes the need for robust preclinical models and translational strategies to overcome challenges such as long-term safety, scalability, and integration with existing wound care protocols. Nanozymes represent a promising “next-generation” approach for complex, multifactorial wounds like DFUs.

Key Highlights:

• Nanozymes combat oxidative stress, infection, and stalled healing in DFUs
• Multifunctional designs (ROS scavenging + antibacterial + pro-regenerative)
• Focus on clinical translation barriers and future design logic
• Strong potential as adjuncts or standalone advanced therapies

Read full open-access editorial

Keywords: nanozymes, nanozymes DFU, oxidative stress wound healing

• Physician CPT 29445 – Application of rigid total contact leg cast (includes use of fiberglass or plaster materials)Facility: ~$90.52Non-Facility (office/clinic): ~$132.60 (National PFS; work RVU 1.74)
• Hospital Outpatient APC 5102 (Level II Strapping & Casting – updated from prior APC 0058)Hospital Outpatient: ~$285.75ASC (reduced rate or component): ~$68.14
• Cast Supply Codes (DMEPOS – billable separately in many settings)Q4038 – Cast supplies, short leg cast, adult (11+), fiberglass: ~$52.48 per unitQ4037 – Cast supplies, short leg cast, adult (11+), plaster: ~$20.92 per unit

  (Payers often limit payable units per application; documentation of type and quantity required.)

Clinical and Billing Context:

TCC application (CPT 29445) is a high-value procedure in limb preservation. It is typically performed in wound care clinics, hospital outpatient departments, or specialized cast rooms. The code covers the full application process, including padding, casting material, and molding for total contact. Separate supply codes (Q4037/Q4038) allow billing for the actual cast materials when used in qualifying settings.

Key considerations for 2026:

• Site-of-service differential significantly impacts payment (non-facility rates are generally higher for physician practices).
• Hospital Outpatient APC 5102 bundles the procedure but allows separate supply billing in many cases.
• Documentation must support medical necessity (e.g., Wagner 1–2 DFU with adequate vascular status, offloading as primary therapy).
• Modifier use (e.g., -RT/-LT, -59) and proper diagnosis coding (e.g., E11.621 Type 2 DM with foot ulcer) are essential for clean claims.
• Many commercial payers follow Medicare rates but may require prior authorization or have higher contracted amounts.

Practical Tips for Wound Care Teams:

• Track material usage carefully — fiberglass is more expensive but lighter and more durable.
• Consider hybrid billing strategies: perform in non-facility clinic when possible for higher physician payment.
• Integrate TCC into multidisciplinary DFU protocols to justify medical necessity and support value-based care metrics.
• Stay alert for annual PFS/OPPS updates and local coverage determinations (LCDs) from your MAC.

Reimbursement Summary Table (2026 Approximate National Averages)

Explore more TCC resources on Wound Care Weekly

Keywords: total contact cast reimbursement, CPT 29445, DFU offloading, TCC 2026, Q4038

Community Pharmacists Support Patients With Chronic Wounds

Summary: Community pharmacists are increasingly positioned to play a key supportive role in chronic wound management. Beyond dispensing dressings and topical agents, they provide patient education on proper wound care techniques, product selection, adherence to treatment plans, and recognition of infection or deterioration signs. The article emphasizes collaboration with wound care specialists, opportunities for counseling on comorbidities (diabetes, vascular disease), and the value of accessible pharmacy-based support in improving healing outcomes and reducing complications in outpatient settings.

Key Highlights:

• Pharmacists deliver education on dressing selection and application
• Support adherence and early detection of complications
• Enhance multidisciplinary care for chronic wounds in community settings

Read full article

Keywords: community pharmacist wound care, chronic wounds management

Assessing Cytotoxic and Antibacterial Effects of High Dispersion-Stable Sub-5 nm Silver Particles

Summary: This research investigates sub-5 nm silver nanoparticles engineered for high colloidal stability. The particles exhibited potent antibacterial effects against common wound pathogens while showing manageable cytotoxicity in relevant cell models. The improved dispersion stability addresses previous limitations of silver nanoparticles (aggregation, inconsistent release, and higher toxicity). Authors suggest potential applications in wound dressings, topical antimicrobials, and infection-prevention coatings where sustained, controlled antibacterial activity is needed without compromising healing.

Key Highlights:

• Sub-5 nm AgNPs with superior dispersion stability
• Strong antibacterial activity with optimized cytotoxicity profile
• Addresses key barriers to clinical translation of silver nanomaterials in wound care

Read full open-access article

Keywords: silver nanoparticles wound, antibacterial wound dressing

Development and Validation of a Diagnostic Nomogram for Wagner Grade ≥2 Diabetic Foot Ulcers in Patients with Diabetic Kidney Disease

Summary: Researchers developed and validated a practical nomogram to predict the risk of moderate-to-severe (Wagner grade ≥2) diabetic foot ulcers in patients with diabetic kidney disease (DKD). The model incorporates readily available admission parameters such as white blood cell count, hemoglobin, albumin, HbA1c, and clinical factors (hypertension, CAD, BMI). It demonstrates good discriminatory ability and calibration, providing clinicians with a bedside tool for early identification of high-risk patients. Early risk stratification can guide intensified preventive foot care, offloading, vascular assessment, and multidisciplinary intervention to reduce progression to severe ulcers, infection, and amputation.

Key Highlights:

• Nomogram based on routine labs and comorbidities for Wagner ≥2 DFU prediction in DKD patients
• Supports early risk stratification and targeted prevention
• Addresses high amputation risk in combined diabetes + kidney disease population

Read full open-access article

Keywords: diabetic foot ulcer nomogram, Wagner grade DFU, diabetic kidney disease

Topical Application of Cellulose Membrane for the Treatment of Non-Healing Venous Leg Ulcers

Summary: This study evaluated a regenerated cellulose membrane (RCM) as a topical dressing for non-healing venous leg ulcers. After initial debridement, the membrane was applied with standard compression therapy. The material supported autolytic debridement, maintained a moist environment, promoted granulation tissue formation, and facilitated epithelialization in chronic venous ulcers that had failed prior standard care. The authors highlight its biocompatibility, ease of use, and potential as an adjunct in hard-to-heal venous leg ulcers, particularly where exudate management and wound bed preparation are challenges.

Key Highlights:

• Effective support for debridement and granulation in refractory venous leg ulcers
• Biocompatible cellulose membrane maintains optimal moist healing environment
• Used alongside compression therapy with positive clinical progression
• Authors: Multiple (Frontiers Bioengineering team)

Read full open-access article

Keywords: cellulose membrane venous ulcer, venous leg ulcers, hard to heal wounds

Dosing Walking Like a Drug: An AI Chatbot for Diabetic Foot Remission Following Limb Reconstruction

Summary: This protocol paper outlines a conversational AI chatbot designed to guide diabetic foot remission after wound healing or limb reconstruction by treating walking and therapeutic footwear as titratable “drugs.” The system integrates daily data (step counts via phone/wearable, paired foot skin temperature differences, shoe wear time, and symptom checks) to assign risk tiers (green/amber/red) and deliver personalized next-day guidance. Activity advances gradually (~500 steps/week) while gated by thermometry (hold/reduce if ≥2.2°C side-to-side difference). Footwear progression starts conservatively and escalates only with stable skin checks. Built on prior SmartBoot sensor work, the single-arm feasibility pilot (n=30) will assess engagement, safety, and implementation before larger trials. The approach aims to bridge the high-relapse gap (up to 40% within a year) through structured, data-driven home monitoring.

Key Highlights:

• AI chatbot titrates walking (~500 steps weekly increments) and footwear based on real-time thermometry and sensors
• 2.2°C temperature difference threshold triggers de-escalation and clinical escalation if persistent
• Addresses 40% recurrence risk with precise, responsive remission guidance
• Authors/key contributors: Lucian Feraru, David Klonoff, Bijan Najafi et al.

Read full protocol article

Keywords: AI chatbot diabetic foot, diabetic foot remission, walking dosing, Bijan Najafi

Physiologic “Action at a Distance”: Neuromodulation, Neuroimmune Signaling, and Limb Preservation in Diabetic Foot Disease

Summary: This in-depth review synthesizes evidence on physiologic neuromodulation techniques that exert beneficial “action at a distance” for limb preservation in diabetic foot disease, CLTI, burns, and trauma. Modalities include high-frequency spinal cord stimulation (SCS; e.g., SENZA-PDN trial: 79% ≥50% pain relief, 62% neurological improvement), splenic peripheral focused ultrasound (pFUS; preclinical 75% faster wound closure via cholinergic anti-inflammatory pathway), remote ischemic conditioning (RIC; up to 75.6% healing vs 36.6% standard care), tibial transverse transport (TTT; 100% healing in ischemic/non-ischemic groups via neovascularization), and lateral tibial periosteum distraction (LTPD; improved ABI and pain). Despite differing entry points (neural, humoral, mechanical), they converge on enhanced microcirculation, angiogenesis, and immunomodulation. While promising, data are mostly early-phase; larger RCTs are needed for amputation-free survival and cost-effectiveness.

Key Highlights:

• SCS: 79% significant pain relief and sensory improvement in diabetic neuropathy
• pFUS and RIC: accelerated healing via anti-inflammatory and conditioning effects
• TTT/LTPD: robust neovascularization and 100% healing in select series
• Authors: Ahmed Sami Raihane, Gabriela Morales Deusch, Charles Liu, Bijan Najafi et al.

Read full review

Keywords: neuromodulation limb preservation, spinal cord stimulation DFU, CLTI neuromodulation, Bijan Najafi

Australian bee glue delivers a scar-fighting compound that shuts down raised scars before they take hold

Summary: Researchers from Australia have identified tomentosenol A, a compound from propolis (bee glue), that shows strong anti-scarring potential. In human cell culture models, the compound blocks key signaling pathways that drive excessive scar formation (hypertrophic and keloid scars) and promotes apoptosis (self-destruction) of scar-forming fibroblasts—mimicking the controlled resolution seen in normal wound healing. This early laboratory work addresses the need for better therapies targeting the root causes of raised, painful, and functionally limiting scars from surgery, injury, or burns. Pre-clinical trials are planned next. The discovery highlights the value of natural product research for regenerative wound care and scar management.

Key Highlights:

• Tomentosenol A from Australian propolis inhibits scarring signals and induces fibroblast apoptosis
• Promotes healing pathways similar to normal (non-scarring) wound resolution
• Potential applications: hypertrophic scars from surgery, trauma, and burns
• Researchers: Lisa Randall (lead PhD student), Fraser Russell, Trong Tran, Robert Harvey et al.

Read full article

Keywords: propolis scar treatment, hypertrophic scars, tomentosenol A, Lisa Randall

Myth: Wound/Ulcer Management Professionals Cannot Receive…

Summary: This citation-style entry in *Advances in Skin & Wound Care* (April 2026) addresses a myth concerning wound and ulcer management professionals. Due to limited accessible full text, the core focus appears to challenge assumptions about restrictions or limitations faced by specialists in the field (e.g., regarding certification, reimbursement, multidisciplinary collaboration, or professional development opportunities). Such myth-busting pieces typically provide evidence-based clarification and practical guidance to empower clinicians in delivering optimal care. Wound care teams are encouraged to stay updated on evolving policies and advocate for their role in comprehensive patient management.

Key Highlights:

• Directly confronts a prevalent misconception in wound/ulcer care practice
• Emphasizes the capabilities and scope of wound management professionals
• Supports multidisciplinary approaches and professional advancement

Read full citation/article

Keywords: wound ulcer management professionals, wound care myths

Skin Cancer and Wound Healing

Summary: This editorial explores the intersection of skin cancer and wound healing, noting that basal cell carcinoma (BCC)—the most common skin cancer—often presents with erosions or ulcerations on sun-exposed skin. Treatment includes excision, curettage, or Mohs microsurgery for facial/larger lesions. A case of a massive (18 × 16.5 cm) shoulder/scapular BCC required vismodegib (Hedgehog inhibitor), radiation, and extensive surgery after secondary infection. Marjolin ulcers (malignant transformation, usually to squamous cell carcinoma/SCC in chronic scars/wounds like burns, pressure injuries, or osteomyelitis sites) are aggressive, with a classic triad of deep nodule, indurated edges, and central ulceration. They carry 20-40% risk of regional lymph node spread and higher mortality; early and repeated biopsies are critical due to sampling error. Two additional cases in the issue illustrate Marjolin SCC in a tibial malunion/osteomyelitis site and a sacral pressure injury. Recommendations include total skin exams for patients with prior skin cancers, vigilance in dark skin tones and high-risk groups (immunosuppressed, hidradenitis suppurativa), foot exams for melanoma, and sun protection (SPF 30-60, wide-brim hats, vitamin D supplementation).

Key Highlights:

• BCC may ulcerate; advanced cases benefit from vismodegib + radiation/surgery (only 1-10% are locally advanced)
• Marjolin SCC in chronic wounds/scars is aggressive with 20-40% nodal metastasis risk; biopsy nonhealing ulcers (repeat if suspicion high)
• Case examples: large BCC requiring multimodal therapy; Marjolin in pressure injury and osteomyelitis sites
• Prevention: sun protection, total skin exams, foot checks (especially in persons of color)
• Authors: R. Gary Sibbald, Elizabeth A. Ayello

Read full editorial

Keywords: skin cancer wound healing, Marjolin ulcer, basal cell carcinoma, R. Gary Sibbald

WHS Recognizes Eluciderm, Inc. with Industrial R&D Award for Research on ELU42 Mechanism of Action

Summary: Eluciderm, Inc. received the Wound Healing Society’s Industrial Research & Development Poster Presentation Award at SAWC Spring 2026 for work on ELU42, a first-in-class topical small-molecule PARP-signaling modulator with bacteriostatic properties. Preliminary data from the first five diabetic foot ulcer (DFU, Wagner Grade 1–2) patients in the ongoing Phase I/IIA SuperHealer42 study showed mean wound area reduction of 40.9% at one week and 86.0% at four weeks, with excellent local tolerability and no treatment-related serious adverse events. Preclinical mechanistic studies (RNA-seq, immunostaining in murine models) demonstrated early suppression of pro-fibrotic genes, subsequent angiogenic activity, and recruitment of SOX9-positive stem cells, supporting a “restorative reset” that favors regenerative rather than scar-mediated healing. ELU42 has potential across chronic wounds, burns, and other indications.

Key Highlights:

• 86.0% mean DFU area reduction at 4 weeks in early clinical data
• Mechanism: PARP modulation suppresses fibrosis, mobilizes reparative stem cells
• WHS Industrial R&D Award at SAWC 2026; second major award for ELU42
• Good safety profile with undetectable systemic absorption

Read full press release

Keywords: ELU42, diabetic foot ulcer healing, PARP signaling, Eluciderm

Surgical Management of Stage 3 and 4 Pressure Injuries in Trauma Patients Using Ovine Forestomach Matrix Grafts: A Prospective Case Series

Summary: This prospective observational case series at a level 1 trauma center evaluated ovine forestomach matrix (OFM) grafts (sheet or granular) as an adjunct in 9 trauma patients with 12 stage 3/4 pressure injuries (75% stage 4, mean area 46 cm², many with tunneling/undermining or osteomyelitis). Following surgical debridement, OFM was applied and covered with non-adherent dressings ± negative pressure wound therapy. Median applications: 1.0. Outcomes included median time to 50% granulation of 2 weeks and complete granulation coverage of 6.5 weeks. Tunneling/undermining resolved in 50% and improved in the rest. Mean percent area reduction at ~23-week follow-up was 61%. No postoperative complications (infection, graft loss, hematoma) occurred. OFM provided immediate coverage, promoted neovascularization, simplified care, and may facilitate later reconstruction or secondary intention healing.

Key Highlights:

• Rapid granulation: median complete coverage 6.5 weeks with typically single application
• Mean 61% area reduction; tunneling/undermining resolved or improved in most
• No complications in complex trauma/spinal cord injury patients
• Authors: Sophia M. Trinh, Kaitlyn Andre, Alison A. Smith et al.

Read full open-access case series

Keywords: ovine forestomach matrix, stage 4 pressure injury, pressure ulcer surgery, Alison A. Smith

A Single-Institution Cohort Study of Autologous Platelet-Rich Plasma Gel for Hard-to-Heal Chronic Wounds: Potential Role in Microvascular Regeneration

Summary: This single-center retrospective cohort evaluated autologous platelet-rich plasma (PRP) gel prepared with the AutoloGel System® in 20 patients with hard-to-heal chronic wounds refractory to ≥28 days of standard wound care. Etiologies included diabetic foot ulcers (n=4), chronic limb-threatening ischemia (n=3), vasculitic ulcers (n=5), venous leg ulcers (n=3), pressure ulcers, and surgical site infections. PRP gel was applied weekly (mean 4.3 applications). All wounds achieved complete epithelialization within 12 weeks, with mean healing time of 47.9 ± 28.5 days after PRP initiation—significantly faster than the 87.2 ± 77.1 days on prior conventional therapy (p=0.0107). No treatment-related adverse events occurred. The therapy showed particular promise in difficult microvascular and vasculitic ulcers, supporting PRP’s potential role in promoting angiogenesis and microcirculatory regeneration.

Key Highlights:

• 100% complete healing within 12 weeks across diverse refractory wounds (including DFUs)
• Healing time reduced from 87.2 to 47.9 days (p=0.0107)
• Effective in vasculitic and microangiopathic ischemic ulcers
• No adverse events; mean 4.3 weekly applications
• Authors: Miki Fujii, Kazuki Shimada, Takako Komiya, Hajime Matsumura

Read full open-access article

Keywords: platelet rich plasma gel, hard to heal wounds, autologous PRP, Miki Fujii

Peripheral Artery Disease in Diabetes

Summary: This open-access mini-review highlights peripheral artery disease (PAD) in type 2 diabetes as a distinct, aggressive entity characterized by diffuse distal arterial involvement, medial arterial calcification (MAC), microvascular dysfunction, neuropathy, and a pro-thromboinflammatory milieu. PAD prevalence in T2D ranges from 12.5%–22% (more than twofold higher than the general population), with faster progression to chronic limb-threatening ischemia (CLTI), foot ulcers, infection, and amputation. MAC doubles amputation risk in diabetic foot ulcers and quadruples it with concurrent chronic kidney disease. Pathophysiology involves hyperglycemia-driven oxidative stress, endothelial dysfunction, AGE-RAGE signaling, platelet hyperreactivity, and impaired fibrinolysis. Diagnostic challenges include unreliable ankle-brachial index (ABI) due to non-compressible vessels; toe-brachial index (TBI), transcutaneous oxygen pressure (TcPO2), and skin perfusion pressure (SPP) are recommended. Management focuses on metabolic optimization, supervised exercise, antithrombotics, revascularization, and emerging agents such as GLP-1 receptor agonists (e.g., semaglutide improving walking distance) and lipid-lowering therapies that reduce ulceration/gangrene.

Key Highlights:

• PAD prevalence 12.5%–22% in T2D; MAC doubles DFU amputation risk (4x with CKD)
• Distinct features: distal diffuse disease, microvascular rarefaction, masked symptoms due to neuropathy
• Improved diagnostics: prefer TBI, TcPO2, SPP over ABI for wound healing prediction
• Emerging therapies: GLP-1 RAs (semaglutide), SGLT2i, PCSK9 inhibitors, and regenerative approaches
• Authors: Sheena Amin, Eri Fukaya, Anand Athavale

Read full open-access review

Keywords: peripheral artery disease diabetes, diabetic foot ulcer amputation, medial arterial calcification, Sheena Amin

Anesthetic Flooding Technique for Sharp Wound Debridement: A Novel Approach to Pain Control and Hemostasis

Summary: Traditional topical anesthesia for sharp wound debridement often provides inconsistent pain control, leading to procedure interruptions or switches to injectable anesthesia. This article introduces a novel “anesthetic flooding” technique in which topical anesthetic is poured directly into the wound base at the start or during debridement as needed. The method delivers continuous anesthesia throughout the procedure while also promoting a clearer visual field through better hemostasis control. It is particularly valuable when conventional topical application fails to manage pain adequately, improving both patient comfort and procedural efficiency without the need for injectable agents. The technique is simple, low-cost, and easily integrated into bedside or clinic-based sharp debridement protocols.

Key Highlights:

• Flooding technique provides continuous anesthesia without interrupting debridement
• Improves hemostasis and maintains a clear visual field
• Reduces need for injectable anesthesia or premature termination
• Authors: Igor Melnychuk, MD, CLT; Julia Juriga, MBS

Read full article

Keywords: anesthetic flooding, sharp debridement, wound pain control, Igor Melnychuk

Use of Synthetic Electrospun Fiber Matrix in the Sealing of Tunneling, Undermining, and Cavity Wounds

Summary: This retrospective case series evaluated the synthetic electrospun fiber matrix (SEFM) in 9 patients with 11 complex wounds featuring tunneling, undermining, or cavities. All wounds underwent initial sharp debridement before SEFM application (particulate or sheet form), combined with various secondary dressings. Patients had significant comorbidities including osteomyelitis, diabetes, peripheral arterial disease, and malnutrition. The SEFM promoted rapid granulation and collapse of dead space, achieving complete resolution of tunneling/undermining in a mean of 17 days. Durable healing was maintained at 6–18 month follow-up with no recurrence in most cases. The matrix resisted enzymatic degradation in contaminated environments and conformed well to irregular wound topography, often avoiding the need for large flap reconstructions or amputation.

Key Highlights:

• Complete resolution of tunneling/undermining and cavities (mean 17 days)
• Avoided flap reconstruction or amputation in complex, comorbid patients
• Effective in traumatic, pressure, and iatrogenic wounds with osteomyelitis
• Authors: Thea Price, MD; Katie Meador, NP

Read full case series

Keywords: electrospun fiber matrix, tunneling wounds, undermining wounds, cavity wounds, Thea Price

Cutaneous Safety Evaluation of Pure Hypochlorous Acid Solution in Preterm Infants and Neonates With Complex Wounds

Summary: This retrospective series evaluated the cutaneous safety and tolerability of a pure hypochlorous acid-preserved cleanser (pHA) in 100 preterm and neonatal patients with complex wounds. Patients received a mean of 7.6 applications over 18.7 days, including the youngest infant born at 21 weeks’ gestation. Across 766 cumulative applications, no cutaneous adverse effects or wound-related complications (contact dermatitis, erythema, chemical burns, infection, or secondary breakdown) were observed. pHA was safely used concurrently with other advanced therapies such as medical-grade honey, negative pressure wound therapy, and extracellular matrix dressings. The physiologic pH and low cytotoxicity profile make pHA a promising gentle cleansing option for fragile neonatal skin in NICU settings, where traditional antiseptics carry higher risk of irritation or delayed healing.

Key Highlights:

• No adverse cutaneous effects in 766 applications across 100 preterm/neonatal patients
• Safe even in extremely preterm infants (as young as 21 weeks gestation)
• Compatible with advanced wound therapies without added complications
• Authors: Rene Amaya, MD; Emily Heisler, MSN, RN, FNP-C

Read full article

Keywords: hypochlorous acid, neonatal wound care, preterm infant skin, Rene Amaya

New Techniques Help Save Limbs as Late Vascular Cases Rise

Summary: Vascular surgeon Dr. Abhineet Kumar at Lautoka Hospital in Fiji highlights the growing burden of late-presenting vascular disease, particularly among diabetic patients with severe foot ulcers and gangrene. Thanks to the adoption of advanced endovascular techniques, monthly amputation rates have decreased from 20–30 cases to 6–10 cases. Dr. Kumar stresses the urgent need for more specialised wound care nurses to improve early intervention and ongoing management. The article underscores how timely vascular assessment, modern techniques, and dedicated wound care teams can significantly reduce preventable amputations in resource-constrained settings.

Key Highlights:

• Amputation rates reduced from 20–30 to 6–10 cases per month with advanced techniques
• Emphasis on early vascular assessment and specialised wound care nursing
• Focus on diabetic foot ulcers and gangrene as major drivers of limb loss
• Call for increased training and resources in wound care to further save limbs

Read full article

Keywords: limb salvage, vascular surgery, diabetic foot amputation, wound care nurse

Wound Care in Community Pharmacy: Practical Guidance for Frontline Teams

Summary: Community pharmacists are often the first healthcare professionals patients consult for minor wounds, post-surgical care, and early chronic wounds. This article provides practical guidance on modern dressing selection (moist wound healing principles), identifying red flags for infection (increasing pain, spreading redness, warmth, pus, or fever), recommending appropriate over-the-counter products, and knowing when to refer to wound care specialists or physicians. Emphasis is placed on evidence-based practices, patient education, and collaboration with other providers to improve healing outcomes and reduce complications in diabetic foot ulcers, pressure injuries, and acute wounds. Pharmacists play a growing role in accessible, timely wound management within primary care.

Key Highlights:

• Community pharmacies serve as accessible first stop for wound assessment and product advice
• Guidance on moist wound healing, dressing selection, and infection recognition
• Clear criteria for timely referral to specialists or physicians
• Supports better outcomes for DFU, pressure injuries, and minor acute wounds

Read full article

Keywords: pharmacy wound care, community pharmacy, wound dressing selection, infection recognition

Designing Multifunctional Antibacterial Hydrogels: A Tri-Pillar Approach Based on Bacteriophages, Nanoparticles, and Natural Polymers

Summary: This 2026 review presents a tri-pillar strategy for designing advanced antibacterial hydrogels by integrating bacteriophages, nanoparticles, and natural polymers. The approach aims to achieve synergistic effects: phages provide targeted bacterial killing, nanoparticles enhance antimicrobial activity and biofilm penetration, and natural polymers offer biocompatibility, moisture retention, and controlled release. Such multifunctional hydrogels address key challenges in chronic wound management, including persistent infection, biofilm formation, and impaired healing. The review discusses formulation strategies, mechanisms of action, and translational potential for infected diabetic foot ulcers, pressure injuries, and other hard-to-heal wounds, highlighting a promising path toward more effective, resistance-mitigating wound dressings.

Key Highlights:

• Tri-pillar design: bacteriophages + nanoparticles + natural polymers
• Synergistic antibacterial, antibiofilm, and pro-healing effects
• Potential applications in chronic and infected wounds including DFU
• Focus on biocompatibility and controlled release for clinical translation

Read full article (open access)

Keywords: antibacterial hydrogels, phage nanoparticle hydrogel, chronic wound dressings

Bacteria Suppress Immune Defenses in Wound Infections

Summary: Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) AMR group discovered that Enterococcus faecalis, a common bacterium in chronic wounds, releases lactic acid to suppress macrophage activation and immune response. Lactic acid enters macrophages through the MCT-1 transporter and binds the GPR81 receptor, blocking downstream NF-κB signaling and preventing effective inflammation and bacterial clearance. In mouse wound models, lactic acid-deficient E. faecalis strains were cleared faster with stronger immune activity. The mechanism also facilitates co-infection with other bacteria like E. coli, explaining why polymicrobial infections in diabetic foot ulcers and other chronic wounds are persistent and difficult to treat. The findings suggest new therapeutic strategies focused on neutralizing acidity or restoring immune function rather than antibiotics alone.

Key Highlights:

• E. faecalis lactic acid inhibits macrophage activation via MCT-1 and GPR81
• Blocks NF-κB signaling, allowing persistent and polymicrobial wound infections
• Stronger immune clearance when lactic acid production is absent in mouse models
• Implications for chronic wounds including DFU and post-surgical infections

Read full article

Keywords: Enterococcus faecalis, lactic acid wounds, macrophage suppression, polymicrobial infections

Identifying Risk Factors Associated with the Severity of Foot Ulcers in Type 2 Diabetic Patients: Evidence from a Hospital-Based Study in Rajshahi, Bangladesh

Summary: This 2026 cross-sectional study analyzed 159 type 2 diabetes patients with foot ulcers at Rajshahi Diabetic Association General Hospital. Severe ulcers (Wagner grades 3–5) occurred in 63.5% of cases and were associated with higher BMI, longer ulcer duration, greater treatment costs, and increased prevalence of peripheral arterial disease (PAD), peripheral neuropathy (PN), poor glycemic control, and prior amputation. Using Firth’s penalized logistic regression, independent predictors of severity were older age, poor glycemic control, PN, PAD, and prior amputation. The predictive model showed excellent performance (AUC 0.924, accuracy 85.5%). The findings emphasize the importance of early screening and aggressive management of modifiable risk factors to prevent progression to severe diabetic foot ulcers and reduce amputation risk in similar settings.

Key Highlights:

• 63.5% of DFU cases classified as severe (Wagner 3–5)
• Independent risk factors: older age, poor glycemic control, PN, PAD, prior amputation
• Strong predictive model (AUC 0.924) with good clinical utility
• Authors: Shah Tanzen Jahan, Durga H. Kutal, Anicha Akter, Md. Selim Reza, Md. Kabirul Islam

Read full article (open access)

Keywords: DFU severity, risk factors diabetic foot, peripheral neuropathy, peripheral arterial disease, Shah Tanzen Jahan

Karnataka Leads National Push on Diabetic Foot Prevention with Launch of PRAIAS Initiative

Summary: Karnataka has launched the PRAIAS (Podiatry Reach Across India for Awareness and Screening) initiative at Gulbarga Institute of Medical Sciences in Kalaburagi to combat the rising burden of diabetic foot complications. Conceptualized by diabetic foot surgeons Dr. Sanjay Sharma and Dr. Pavan Belehalli and driven by FootSecure and StrideAide, the program features India’s first Digital Podiatry Screening Van equipped with advanced diagnostic tools. The mobile unit will travel across the country, focusing on underserved and remote areas to provide screening, awareness, and early intervention. Globally, a limb is lost every 20 seconds due to diabetes; in India, a new diabetic foot ulcer develops every 12 seconds. The initiative aims to reduce amputations through timely detection, education, and lifestyle management, with strong support from Karnataka’s Minister for Medical Education.

Key Highlights:

• First-of-its-kind Digital Podiatry Screening Van for nationwide outreach
• Focus on early detection and prevention in rural/underserved communities
• Led by Dr. Sanjay Sharma and Dr. Pavan Belehalli; supported by FootSecure and StrideAide
• Addresses alarming statistics: limb lost every 20 seconds globally due to diabetes

Read full article

Keywords: PRAIAS initiative, diabetic foot prevention, screening van, Sanjay Sharma

The Crosstalk Between Efferocytosis and Macrophage Polarization in Diabetic Wounds: A Comprehensive Review

Summary: This comprehensive 2026 review examines how defective efferocytosis (clearance of apoptotic cells) in the diabetic wound microenvironment impairs the transition of macrophages from pro-inflammatory M1 to pro-healing M2 phenotype, leading to persistent inflammation and delayed healing. Hyperglycemia, AGEs, oxidative stress, hypoxia, biofilms, and senescence disrupt efferocytosis receptors (e.g., MerTK) and signaling pathways including JAK/STAT, PI3K/Akt, NLRP3 inflammasome, NF-κB, and MAPK. Failed efferocytosis deprives macrophages of anti-inflammatory signals (TGF-β, IL-10), locking them in M1 dominance. The review discusses therapeutic strategies such as small molecules, natural compounds, and biomaterials (e.g., MerTK nanoparticles, hydrogels) to restore efferocytosis and promote M2 polarization, offering new avenues to overcome limitations in current diabetic wound treatments.

Key Highlights:

• Impaired efferocytosis blocks M1-to-M2 switch in diabetic wounds
• Key disrupted pathways: MerTK downregulation, NLRP3 activation, NF-κB sustained signaling
• Potential therapies target AC clearance and polarization reprogramming
• Authors: Yuxin He, Jie Hu, Anqi Ma, Peiyang Du, Mengdie Yang

Read full article (open access)

Keywords: efferocytosis, macrophage polarization diabetic, diabetic wound inflammation, Yuxin He

Bioactive Platinum Nanozymes Accelerate Diabetic Wound Healing via Anti-Inflammation and Macrophage Polarization Modulation

Summary: Researchers developed sodium hyaluronate-assisted platinum nanozymes (SHA-PtNPs) with excellent catalase-like (3320 U/g) and superoxide dismutase-like (129,000 U/g) activities for efficient ROS scavenging. In streptozotocin-induced diabetic rat full-thickness wound models, topical SHA-PtNPs achieved 97.06% wound closure by day 15 and near-complete healing by day 28, with significantly smaller residual wound areas compared to controls. Mechanisms include suppression of pro-inflammatory cytokines (IL-1β), elevation of anti-inflammatory IL-4 and TGF-β1, promotion of M1-to-M2 macrophage polarization (increased CD206/CD86 ratio), and enhanced angiogenesis (upregulated CD31 and α-SMA). Histology showed reduced inflammation, increased collagen deposition, thicker re-epithelialization, and minimal scarring. The biocompatible nanozyme offers a promising multifunctional approach for chronic diabetic wounds by integrating antioxidant, immunomodulatory, and regenerative effects.

Key Highlights:

• 97% wound closure by day 15 in diabetic rat model
• Strong ROS scavenging via CAT- and SOD-mimicking activity
• Promotes M1-to-M2 macrophage shift and angiogenesis
• Authors: Liyong Shi, Jing Cheng, Lianshun Lin, Tanwei Liu, Linlin Chen

Read full article (open access)

Keywords: platinum nanozymes, diabetic wound healing, macrophage polarization, ROS scavenging, Liyong Shi

Diabetic Foot Disease: Current Challenges, Emerging Concepts and Future Directions

Summary: This open MDPI Topic Collection highlights diabetic foot disease as a major diabetes complication, with 19–34% lifetime risk of foot ulcers and 9–26 million new cases annually worldwide. It leads to lower-limb amputations, reduced quality of life, high healthcare costs, and mortality rates comparable to many cancers. While much research focuses on acute ulcer and infection management, significant gaps remain in prevention, recurrence, long-term outcomes, multidisciplinary care models, health economics, and implementation science. The collection welcomes submissions on innovative diagnostics, prevention strategies, patient-centered care, and emerging paradigms to improve outcomes and sustainability of diabetic foot care systems.

Key Highlights:

• Emphasizes prevention and long-term management beyond acute care
• Calls for multidisciplinary approaches and implementation research
• Addresses global burden including high amputation and recurrence rates
• Open for submissions on diagnostics, economics, and novel therapies

View topic collection

Keywords: diabetic foot disease, DFU prevention, multidisciplinary foot care

AVITA Medical’s Cohealyx Slashes Time to Skin Grafting by Nearly 20 Days in Interim Study

Summary: Interim results from the multi-center Cohealyx-I study show that AVITA Medical’s Cohealyx dermal matrix dramatically shortens time to skin grafting in full-thickness wounds. Compared with a literature benchmark (meta-analysis of ~900 patients using leading dermal matrices), Cohealyx reduced average grafting time from 33.2 days to 13.6 days (nearly 20-day improvement, p<0.001). In 40 patients, median time was 11 days, with 25% grafted within one week and 72% within two weeks. Investigators reported 90% satisfaction, even among first-time users. Cohealyx prepares a vascularized wound bed efficiently, complementing AVITA’s RECELL technology for autologous skin regeneration and offering potential benefits in burn and complex wound management.

Key Highlights:

• Nearly 20-day reduction in time to grafting (33.2 → 13.6 days, p<0.001)
• 72% of patients grafted within 2 weeks; some as early as 5 days
• 90% investigator satisfaction rate
• Supports faster wound bed preparation for subsequent grafting

Read full announcement

Keywords: Cohealyx dermal matrix, skin grafting time, full thickness wounds, AVITA Medical

Spot-on phage therapy: stable formulations, smarter dosing for topical phage application

Summary: This 2026 review addresses key barriers to clinical adoption of topical bacteriophage therapy for wound and burn infections amid rising antimicrobial resistance. It synthesizes data on phage titers (typically 10^7–10^9 PFU/mL), multiplicity of infection (MOI), formulation stability (hydrogels, cetomacrogol creams, polymer sprays, chitosan films), and delivery via wound dressings. Mature biofilms require higher/repeated dosing or combination with depolymerase-armed phages and antibiotics for effective clearance. The authors emphasize standardized PK/PD frameworks, rigorous stability testing (e.g., creams stable up to 90 days at 4°C), and precise dosing protocols to translate phage therapy from lab to bedside for biofilm-related wound infections.

Key Highlights:

• Therapeutic phage concentrations and MOI guidance for planktonic vs. biofilm bacteria
• Stable formulations (hydrogels, creams, sprays) preserve activity and enable controlled release
• Strategies for mature biofilms: repeated dosing, cocktails, or enzymatic combinations
• Authors: Sandhu JS, Parida A

Read full article (open access)

Keywords: phage therapy wounds, topical phage application, biofilm wound infections, Sandhu JS

MediWound Highlights Consensus Supporting Debridement Strategy

Summary: MediWound announced publication of a peer-reviewed supplement in WOUNDS featuring findings from a U.S.-based multidisciplinary consensus panel on debridement in chronic wounds. The panel redefines debridement as a biologically active process that drives healing by reducing biofilm and bacterial load, rather than mere removal of non-viable tissue. Experts recommend initiating treatment with effective, less invasive modalities when clinically appropriate, reserving surgical debridement for specific indications. The consensus highlights the gap in single-modality solutions and underscores the need for easy-to-use, clinically effective first-line therapies. MediWound’s enzymatic products (NexoBrid for burns; EscharEx in development for chronic wounds) align with this framework, with ongoing Phase III trials in venous leg ulcers and planned studies in diabetic foot and pressure ulcers.

Key Highlights:

• Debridement reframed as active intervention targeting biofilm and bacteria
• Preference for less invasive approaches first; surgical reserved for indicated cases
• Supports enzymatic debridement strategies like bromelain-based therapies
• Implications for standardized, effective chronic wound management

Read full article

Keywords: debridement consensus, chronic wound debridement, EscharEx, biofilm management

Smart Patch Boosts Wound Healing Speed

Summary: Researchers have developed a self-regulating “smart patch” that integrates OLED light therapy with controlled drug delivery to accelerate wound healing. The patch autonomously adjusts treatment intensity based on the wound’s condition when attached to the site, enabling personalized medicine through light-triggered drug release. Early indications suggest it can speed wound recovery by up to twice the normal rate, improving patient outcomes and reducing healing time for various wounds. This innovation addresses limitations of traditional dressings by providing dynamic, adaptive therapy and holds promise for chronic and hard-to-heal wounds.

Key Highlights:

• Autonomous regulation of light and drug delivery for personalized treatment
• Accelerates healing by up to 2× normal speed
• Combines phototherapy with on-demand pharmacotherapy
• Potential to improve outcomes in chronic and acute wounds

Read full article

Keywords: smart patch wound healing, OLED wound therapy, personalized wound care, light drug delivery

UGM Student Develops Affordable RAP-VAC Innovation for Wound Therapy

Summary: A doctoral student at Universitas Gadjah Mada (FKKMK UGM), Meirizal, has created RAP-VAC (Reverse Aqua Pump–Vacuum Assisted Closure), an affordable innovation in negative pressure wound therapy. Commercial VAC systems accelerate healing but are prohibitively expensive in resource-limited settings. In a non-inferiority randomized clinical trial at Dr. Sardjito General Hospital (Yogyakarta), RAP-VAC demonstrated comparable efficacy to standard VAC in wound granulation, time to reconstruction, and patient comfort among 24 patients with complex wounds requiring skin grafting. RAP-VAC showed advantages in lower wound infection rates and significantly reduced treatment costs. This cost-effective alternative supports preparation of complex wounds for advanced surgical reconstruction and has strong potential for broader adoption in developing countries facing high chronic wound burdens.

Key Highlights:

• RAP-VAC matches commercial VAC in granulation and healing outcomes but at much lower cost
• Non-inferiority RCT (n=24): no significant differences in key metrics; better infection control in RAP-VAC group
• Designed for complex wounds as a bridge to skin grafting in hand/microsurgery reconstruction
• Developer: Meirizal (doctoral student, Faculty of Medicine, Public Health, and Nursing, UGM)

Read full article

Keywords: RAP-VAC, negative pressure wound therapy, affordable VAC alternative, skin grafting preparation, Meirizal

Pilot Study Could Improve Treatment of Chronic Diabetic Foot Ulcers

Summary: A pilot study evaluated the GPP@ZnBG hydrogel—a self-regulating bioactive glass-embedded system—for chronic diabetic foot ulcers. The hydrogel dynamically responds to wound pH and glucose/oxidative stress: early alkaline conditions trigger controlled zinc ion release for antibacterial effects, while later degradation releases zinc, calcium, and silicate ions to promote angiogenesis and tissue repair. In the clinical pilot, treated ulcers showed a 94.57% relative reduction in wound surface area within 4 weeks. This active nanotechnology approach addresses persistent infection, inflammation, and impaired healing better than passive standard care and highlights pharmacists’ role in advanced product selection and patient education.

Key Highlights:

• 94.57% wound area reduction in 4 weeks for chronic DFU
• pH-responsive zinc delivery: antibacterial early, pro-angiogenic later
• Addresses biofilm, ROS, and poor perfusion in diabetic wounds
• Study authors: Zhao L, Chen S, Chen S, et al.

Read full article

Keywords: DFU hydrogel, bioactive glass wound care, chronic diabetic foot ulcer, zinc ion therapy

A multi therapy bioelectronic wound dressing

Summary: Researchers developed a flexible bioelectronic wound dressing integrating electric field (EF) therapy and on-demand iontophoretic drug delivery (fluoxetine) via integrated microfluidics. In a porcine excisional wound pilot, the dressing significantly improved closure rates, reduced inflammatory cytokines (IL-1β, IL-6, TNF), increased reparative factors (TGF-β1, IGF-1), decreased granulocytes, and produced more mature granulation tissue compared with standard care. The device allows sequential therapy—early EF to enhance galvanotaxis and later fluoxetine to modulate inflammation—offering a smart, localized approach with minimal off-target effects for chronic and acute wounds.

Key Highlights:

• Combines EF therapy (galvanotaxis) with programmable fluoxetine delivery
• Porcine study: faster closure (p=0.0145), reduced inflammation, improved tissue maturity
• Microfluidic switching enables stage-specific treatment
• Authors include Hsin-ya Yang, Jaime Tenedorio, Roslyn Rivkah Isseroff, Marco Rolandi et al.

Read full article

Keywords: bioelectronic wound dressing, electric field therapy, chronic wound innovation, Hsin-ya Yang

A 67-year-old man with diabetes presenting with a foot ulcer

Summary: This CMAJ case discusses a 67-year-old man with diabetes presenting with a foot ulcer. Key management principles include prompt offloading using a nonremovable knee-high device (e.g., total contact cast or nonremovable walker), assessment for infection and ischemia, glycemic optimization, and referral to a foot specialist (podiatrist, wound care nurse, or chiropodist). The article emphasizes daily foot checks, pressure offloading to reduce mechanical stress, and multidisciplinary care to prevent progression and complications such as amputation. It serves as a practical primer aligning with evidence-based diabetic foot guidelines.

Key Highlights:

• Offloading is cornerstone: prefer nonremovable knee-high total contact cast or walker
• Assess for infection, peripheral artery disease, and neuropathy
• Refer early to podiatry or wound care specialist; daily foot inspection advised
• Emphasizes prevention of recurrence in high-risk diabetic patients

Read full case

Keywords: diabetic foot ulcer case, total contact cast, offloading, diabetic foot management

GPCRs as key regulators in wound healing

Summary: This 2026 review explores the critical role of G-protein-coupled receptors (GPCRs) in orchestrating wound healing phases (hemostasis, inflammation, proliferation, remodeling). GPCRs modulate immune cell chemotaxis, platelet aggregation, keratinocyte migration/proliferation, macrophage polarization, and key signaling cascades including Hedgehog-GLI, Hippo-YAP/TAZ, and Wnt/β-catenin. In diabetic and chronic wounds, specific GPCRs (e.g., P2Y12, CXCR4, BLT2, AT1R) influence inflammation resolution, angiogenesis, and re-epithelialization. Agonists/antagonists targeting GPCRs show promise for accelerating healing, with examples including prostacyclin analogs for DFU perfusion and CXCR4 antagonists for progenitor cell recruitment. The review highlights GPCRs as versatile drug targets for improving outcomes in hard-to-heal wounds.

Key Highlights:

• GPCRs regulate immune infiltration, cell migration, and multiple healing pathways (Hedgehog, Hippo, Wnt)
• Relevance to DFU: P2Y12 promotes resolution; CXCR4 antagonism and BLT2 activation improve diabetic healing
• Therapeutic examples: beraprost/iloprost, losartan, AMD3100, PGE2 hydrogels
• Authors: Haidi Chen, Kun Zheng, Yue Xiao, Xun Feng, Chang Zhang, Ting Zhang

Read full article (open access)

Keywords: GPCRs wound healing, chronic wound mechanisms, diabetic foot ulcer therapy, macrophage polarization, Haidi Chen

Identifying Risk Factors Associated with the Severity of Foot Ulcers in Type 2 Diabetic Patients: Evidence from a Hospital-Based Study in Rajshahi, Bangladesh

Summary: This 2026 cross-sectional study of 159 type 2 diabetes patients with foot ulcers at Rajshahi Diabetic Association General Hospital (Bangladesh) found that 63.5% had severe DFU (Wagner grades 3–5). Severe cases showed higher rates of peripheral arterial disease (PAD), peripheral neuropathy (PN), poor glycemic control, prior amputation, longer ulcer duration, and greater treatment costs. Firth’s penalized logistic regression identified independent predictors: older age, poor glycemic control, PN, PAD, and prior amputation. The predictive model demonstrated strong performance (AUC 0.924, accuracy 85.5%). Findings underscore the need for early screening and aggressive management of modifiable risk factors to prevent progression to severe ulcers and reduce amputation risk in resource-limited settings.

Key Highlights:

• 63.5% of DFU cases were severe (Wagner 3–5); higher costs and complications in severe group
• Independent risk factors: older age (aOR 1.08), poor glycemic control (aOR 3.90), PN (aOR 3.41), PAD (aOR 7.54), prior amputation (aOR 13.67)
• Strong model performance with good calibration and clinical utility
• Authors: Shah Tanzen Jahan, Durga H. Kutal, Anicha Akter, Md. Selim Reza, Md. Kabirul Islam, Md. Monimul Huq

Read full article (open access)

Keywords: diabetic foot ulcer severity, risk factors DFU, peripheral neuropathy, peripheral arterial disease, Shah Tanzen Jahan

New Clinical Data on Fish-Skin Grafts to Headline Kerecis Presence at SAWC Spring

Summary: Kerecis, pioneer of intact fish-skin graft technology, will feature new clinical data at the Symposium on Advanced Wound Care (SAWC) Spring 2026 in Charlotte, North Carolina (April 8–11). Presentations will include results on fish-skin grafts for pressure ulcers and other challenging wounds, reinforcing the platform’s ability to support tissue regeneration through its natural structure and antimicrobial properties. The company will also showcase its expanded portfolio and complementary Biatain dressings at Booth 1508, along with an industry-supported symposium. This highlights growing multi-specialty adoption of fish-skin grafts in advanced wound care.

Key Highlights:

• New data on fish-skin grafts for pressure ulcers
• 13 abstracts on intact fish-skin technology
• Showcase at SAWC Spring 2026 with expanded portfolio
• Emphasizes evidence-based biologic wound solutions

Read full article

Keywords: fish skin grafts, Kerecis, SAWC Spring, pressure ulcer

Pilot Study Could Improve Treatment of Chronic Diabetic Foot Ulcers

Summary: This pilot study evaluates a novel self-regulating hydrogel (GPP@ZnBG) for chronic diabetic foot ulcers. The hydrogel uses a pH-responsive mechanism: in the early alkaline inflammatory phase it releases zinc ions for antibacterial action, then degrades in the later healing phase to deliver zinc, calcium, and silicate ions that support angiogenesis and tissue regeneration. In the pilot, it achieved a 94.57% relative reduction in wound surface area within 4 weeks. The approach addresses key barriers in DFU healing (infection, inflammation, poor angiogenesis) more actively than conventional passive dressings. Results suggest potential for better outcomes and reduced amputation risk, with pharmacists playing a key role in adoption and patient education.

Key Highlights:

• Self-regulating pH-responsive zinc and bioactive ion release
• 94.57% relative wound area reduction in 4 weeks
• Targets infection, inflammation, and impaired angiogenesis
• Potential advancement over standard DFU dressings

Read full article

Keywords: diabetic foot ulcers, GPP@ZnBG hydrogel, self regulating hydrogel, chronic DFU treatment

A multi therapy bioelectronic wound dressing

Summary: This study introduces a flexible bioelectronic wound dressing that combines multiple therapies in one device, including electric field (EF) stimulation and controlled drug delivery via integrated microfluidics. The dressing applies EF to promote galvanotaxis and cell migration, then switches to iontophoretic delivery of fluoxetine to modulate inflammation. In a pilot porcine excisional wound model, treated wounds demonstrated significantly faster closure, reduced inflammatory response (lower granulocytes and pro-inflammatory cytokines), and improved tissue maturity compared to standard care. The technology enables localized, on-demand treatment with minimal off-target effects, offering a promising platform for chronic and acute wounds, including diabetic foot ulcers.

Key Highlights:

• Combines EF therapy and drug delivery in a single flexible dressing
• Microfluidics enable seamless switching between modalities
• Pilot porcine study: faster closure, less inflammation, better tissue quality
• Authors: Hsin-ya Yang, Jaime Tenedorio, Marco Rolandi (corresponding)

Read full article

Keywords: bioelectronic wound dressing, electrical stimulation, chronic wound therapy, Marco Rolandi

Quality of Clinical Practice Guidelines for Diabetic Foot Management: A Systematic Review Using the AGREE II and AGREE-REX Instruments

Summary: This systematic review assessed the methodological quality and recommendation excellence of 15 clinical practice guidelines (CPGs) for diabetic foot ulcer (DFU) management using AGREE II and AGREE-REX instruments. Six guidelines were rated high-quality and nine moderate-quality. Highest AGREE II domains were Editorial Independence, Scope and Purpose, and Clarity of Presentation. Lowest scores were in Applicability, Stakeholder Involvement, and Rigor of Development. AGREE-REX showed weaknesses in Values and Preferences. Seventeen key treatment recommendations were synthesized, mostly Grade B with moderate-quality evidence. The review concludes that while guidelines use systematic methods, gaps remain in applicability, stakeholder input, and implementation. Future guidelines should prioritize these areas and strengthen underlying evidence to improve clinical utility and patient outcomes.

Key Highlights:

• Variability in quality; strong in scope/clarity but weak in applicability and rigor
• Low scores in stakeholder involvement and values/preferences
• Recommendations mostly Grade B with moderate evidence
• Authors: Yu Song, Zhong-Fei Cui, Zhi-Qiang Wu, Xiao-Bo Liu, Wen-Jun Liu et al.

Read full review (open access)

Keywords: DFU guidelines, AGREE II, diabetic foot management, clinical practice guidelines, Yu Song

Podiatric Care Associated with Reduced Mortality and Enhanced Amputation-Free Survival

Summary: This longitudinal observational study evaluated the impact of podiatric care on clinical and healthcare utilization outcomes in patients with diabetic foot ulcers (DFUs). Among 2798 patients (mean age 65.7 years) in Singapore’s DEFINITE Care program with at least 12 months follow-up, those receiving podiatric care (n=1212) were compared to those without (n=1586). Podiatric follow-up was associated with significantly lower mortality (7.4% vs 19.5%, adjusted OR 0.314, p<0.01) and higher amputation-free survival (adjusted OR 1.26, p=0.02), despite more minor LEAs and increased healthcare utilization (more admissions, ED, and outpatient visits, but shorter length of stay). Patients with podiatric care were more likely to have prior ulcers, poorer glycemic control, and comorbidities. The findings highlight podiatric care’s value in improving survival and limb preservation in Asian DFU populations.

Key Highlights:

• Lower mortality and better amputation-free survival with podiatric care
• More minor LEAs but overall positive limb salvage impact
• Increased short-term healthcare use but shorter length of stay
• Authors: Wen Zhe Leo (corresponding), Lixia Ge, Chelsea Law, Tiffany Chew, Jo Ann Lim et al.

Read full article (open access)

Keywords: podiatric care, diabetic foot ulcer, amputation free survival, limb salvage, Wen Zhe Leo

Bacteria Suppress Immune Defenses in Wound Infections

Summary: Recent research has uncovered mechanisms by which pathogenic bacteria suppress the host immune response during wound infections. The study shows that specific bacterial strategies can dampen immune cell activity, allowing persistent infection and delayed healing in chronic wounds. These findings deepen understanding of host-pathogen interactions and open new avenues for developing targeted therapies that counteract bacterial immune evasion. By addressing these suppression tactics, future wound care approaches could restore effective immune function and accelerate healing in difficult-to-treat infected wounds.

Key Highlights:

• Bacteria employ active strategies to suppress immune defenses
• Mechanism contributes to chronicity and poor healing in wounds
• Offers new targets for anti-infective and immunomodulatory therapies
• Relevance: Advances understanding of infected chronic wounds

Read full article

Keywords: bacterial immune suppression, wound infection, chronic wound healing

New Clinical Data on Fish-Skin Grafts to Headline Kerecis Presence at SAWC Spring

Summary: Kerecis, known for its proprietary fish-skin graft technology, will feature new clinical data at the Symposium on Advanced Wound Care (SAWC) Spring 2026. The presentations include results on the use of fish-skin grafts for pressure ulcers and other challenging wounds. The data further supports the efficacy of this intact fish-skin matrix in promoting healing through its natural structure, antimicrobial properties, and ability to support tissue regeneration. The company will also showcase its broader portfolio and commitment to evidence-based advanced wound care solutions during the conference in Charlotte, North Carolina (April 8–11, 2026).

Key Highlights:

• New clinical data on fish-skin grafts for pressure ulcers
• Evidence supporting unique biologic properties and healing outcomes
• Featured at SAWC Spring 2026 in Charlotte
• Strengthens position in advanced wound care biologics

Read full article

Keywords: fish skin grafts, Kerecis, SAWC Spring, pressure ulcer treatment

Pilot Study Could Improve Treatment of Chronic Diabetic Foot Ulcers

Summary: A recent pilot study suggests promising new strategies for treating chronic diabetic foot ulcers (DFUs), a condition that remains difficult to manage despite standard care. The research evaluates innovative interventions aimed at overcoming biological barriers such as impaired angiogenesis, persistent inflammation, and biofilm formation. Early results indicate potential for faster wound closure and reduced complication rates. While larger trials are needed, the findings highlight opportunities to expand the therapeutic toolbox for DFUs and improve limb salvage outcomes for patients with diabetes.

Key Highlights:

• Focuses on chronic, hard-to-heal diabetic foot ulcers
• Explores novel approaches targeting key healing barriers
• Early data shows potential for improved closure rates
• Addresses a critical gap in current DFU treatment options

Read full article

Keywords: diabetic foot ulcers, DFU pilot study, chronic wound treatment

A multi therapy bioelectronic wound dressing

Summary: Researchers have developed a multi-therapy bioelectronic wound dressing that integrates several active healing mechanisms into one advanced platform. The dressing delivers controlled electrical stimulation alongside other therapeutic effects to promote faster wound closure, reduce inflammation, and combat infection. In preliminary testing, the device demonstrated encouraging results in managing chronic and complex wounds. By combining multiple modalities, it addresses several barriers to healing simultaneously. This innovation represents a step toward smarter, more effective wound care devices that could reduce healing times and improve outcomes in difficult-to-treat cases such as diabetic foot ulcers and pressure injuries.

Key Highlights:

• Integrates multiple therapeutic modalities in one dressing
• Delivers electrical stimulation with additional synergistic effects
• Promising early results for chronic and complex wounds
• Potential to accelerate healing and reduce treatment burden

Read full article

Keywords: bioelectronic wound dressing, electrical stimulation, advanced wound dressing, chronic wound therapy

Agiliti Introduces Capillaire™ — Low-Profile Alternating Pressure Overlay Clinically Proven to Prevent Perioperative Pressure Injuries

Summary: Agiliti has introduced Capillaire™, a new low-profile alternating pressure overlay specifically designed to prevent pressure injuries during surgery. The device is clinically proven to reduce the incidence of perioperative pressure injuries in high-risk patients. Its slim design allows seamless integration under the patient on standard operating tables without disrupting surgical workflows. The overlay delivers dynamic pressure redistribution while maintaining a low profile, addressing a critical gap in intraoperative skin protection. This launch strengthens Agiliti’s portfolio of advanced support surfaces and offers hospitals a practical, evidence-based tool to improve patient safety and reduce costly hospital-acquired pressure injuries.

Key Highlights:

• Clinically proven reduction in perioperative pressure injuries
• Low-profile design compatible with standard OR tables
• Dynamic alternating pressure redistribution for high-risk surgical patients
• Addresses a key gap in intraoperative skin integrity management

Read full announcement

Keywords: perioperative pressure injury, alternating pressure overlay, Capillaire, pressure injury prevention

Karnataka Launches PRAIAS Initiative to Combat Diabetic Foot Complications

Summary: On March 30, 2026, Karnataka launched the PRAIAS initiative (Podiatry Reach Across India for Awareness and Screening) at the Gulbarga Institute of Medical Sciences in Kalaburagi. The program aims to tackle India’s massive diabetic foot burden—where a new diabetic foot ulcer develops every 12 seconds and a limb is lost globally every 20 seconds—through prevention, early detection, and public awareness. Key component: a Digital Podiatry Screening Van equipped with advanced tools to assess foot pressure, neuropathy, and circulation. The initiative follows a structured outreach model across cities, integrating technology and data analysis for risk stratification and timely intervention. Goal: achieve zero preventable amputations through education, screening, and clinical support in collaboration with diabetic foot specialists and healthcare organizations.

Key Highlights:

• Launch of mobile screening van with advanced diagnostic tools
• Focus on early detection of neuropathy, pressure issues, and vascular risk
• Structured awareness and outreach to reduce amputations
• Relevance: Scalable public health model for high-burden diabetic foot care

Read full article

Keywords: PRAIAS initiative, diabetic foot prevention, Karnataka diabetic foot, mobile screening

Artificial Intelligence–Enhanced Wound Care to Improve Access, Efficacy, and Equity in Wound Care for Older Adults in Rural and Remote Regions of Canada

Summary: This 2026 viewpoint paper by Courtney Genge and colleagues advocates for wider adoption of AI-enhanced digital wound care technology (DWCT) to address inequities in wound management for older adults in rural and remote Canadian regions. Drawing on literature and real-world implementations in Ontario community health systems (including an Indigenous-led service), the authors highlight how AI tools improve wound measurement accuracy, tissue classification, healing trajectory prediction, and multidisciplinary communication. Benefits observed include reduced specialist travel (over 1000 km saved in one year), faster healing in high-risk cases, fewer emergency visits, and better patient engagement. The technology helps overcome workforce shortages, geographic barriers, and assessment variability, promoting timely interventions and supporting aging-in-place. Calls for broader implementation and policy support to scale equitable wound care.

Key Highlights:

• AI improves accuracy of wound assessment and reduces subjectivity
• Significant time and travel savings in rural/remote settings
• Enhanced equity and outcomes for older adults with chronic wounds
• Authors: Courtney Genge, Basnama Ayaz, Shannon Freeman, Heba Tallah Mohammed et al.

Read full article (open access)

Keywords: AI wound care, digital wound technology, rural wound care, Courtney Genge

Collagen Products in the Treatment of Chronic Wounds

Summary: This educational resource from Wounds Africa discusses the role of collagen products in the management of chronic wounds. It covers different collagen dressing types, their mechanisms (providing a scaffold for cell migration, promoting granulation, modulating matrix metalloproteinases, and supporting moist healing), and clinical indications for diabetic foot ulcers, venous leg ulcers, pressure injuries, and other non-healing wounds. Practical guidance on selection, application, and expected outcomes is included, positioning collagen products as a valuable tool in advanced wound bed preparation and progression toward healing when standard care is insufficient.

Key Highlights:

• Collagen provides structural scaffold and modulates wound environment
• Useful in chronic wounds with stalled healing or excessive proteases
• Practical guidance for selection and use in various wound types
• Relevance: Accessible resource for clinicians in resource-variable settings

Read resource

Keywords: collagen dressings, chronic wounds, wound bed preparation

Graphene Far-Infrared Therapy Enhances Diabetic Wound Healing Through Potential Mitigation of Oxidative Stress and Inflammation and Regulation of Chemokines and Macrophage Polarization

Summary: This 2026 preclinical study evaluates graphene-based far-infrared (FIR) radiation therapy in a streptozotocin-induced diabetic rat full-thickness wound model. Graphene FIR significantly accelerated wound closure (reaching 83.9% healing by day 14 versus 66.8% in untreated controls), improved re-epithelialization, collagen deposition, and neovascularization. Mechanistic analyses (RNA sequencing, qRT-PCR, immunofluorescence, and high-glucose cell assays) showed reduced ROS accumulation, downregulation of pro-inflammatory chemokines (Cxcl2/Cxcl3), suppression of M1 macrophage polarization with promotion of M2 shift, and inhibition of NF-κB signaling. These coordinated immunomodulatory and antioxidant effects restored a pro-regenerative microenvironment. The noninvasive approach offers promise as an adjunctive therapy for hard-to-heal diabetic foot ulcers.

Key Highlights:

• Accelerated wound closure and tissue remodeling in diabetic models
• Reduced oxidative stress and inflammation via ROS downregulation
• Macrophage polarization shift (M1 suppression, M2 promotion) and chemokine regulation
• Authors: Xinyu Jian, Xuanjun Wu, Xian Luo, Chengwei Cao, Qianwen Wu, Ziwen Chen et al.

Read full article (open access)

Keywords: graphene FIR, diabetic wound healing, macrophage polarization, oxidative stress, Xinyu Jian

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

Summary: In this March 31, 2026 announcement, FibroBiologics, Inc. (Nasdaq: FBLG) reports successful completion of cGMP manufacturing for its investigational fibroblast-derived therapy CYWC628. The product is advancing to support a first-in-human Phase 1/2 clinical trial evaluating safety and efficacy in patients with refractory diabetic foot ulcers (DFUs). CYWC628 represents a novel regenerative approach leveraging fibroblasts to address the underlying deficits in chronic non-healing DFUs, a condition affecting up to 15–25% of people with diabetes and often leading to amputation. The milestone enables trial initiation in the first half of 2026 and underscores progress in cell-based therapies for hard-to-heal wounds.

Key Highlights:

• Successful cGMP manufacturing of CYWC628 completed
• Prepares for Phase 1/2 trial in refractory DFU patients
• Fibroblast-based regenerative platform targeting chronic wound deficits
• Addresses high unmet need in diabetic foot ulcer management

Read full announcement

Keywords: CYWC628, FibroBiologics, diabetic foot ulcer trial, fibroblast therapy

Hydrogel-Delivered Recombinant Fibronectin DK1 Promotes Diabetic Wound Healing by Boosting Cellular Responses

Summary: This 2026 preclinical study (Shiwen Chen et al.) develops a hydrogel system for sustained delivery of recombinant fibronectin fragment DK1 to treat diabetic wounds. In streptozotocin-induced diabetic mouse models with full-thickness wounds, the DK1-hydrogel significantly accelerated wound closure rates, improved re-epithelialization, enhanced collagen deposition and organization, promoted angiogenesis, and boosted fibroblast/keratinocyte proliferation and migration compared to controls. It also reduced excessive inflammation. The biocompatible hydrogel provides a moist environment and controlled release, addressing key barriers in diabetic foot ulcer healing. Results support further development of fibronectin-based biomaterial therapies as a promising advanced dressing approach.

Key Highlights:

• DK1-hydrogel accelerates closure and re-epithelialization in diabetic models
• Enhances collagen, angiogenesis, and cellular proliferation/migration
• Reduces inflammation while maintaining biocompatibility
• Authors include Shiwen Chen (lead/corresponding contributors noted in publication)

Read full article (open access)

Keywords: DK1 hydrogel, fibronectin diabetic wound, diabetic wound healing, Shiwen Chen

Mitochondria-mediated inflammation and diabetic wound healing: mechanisms and therapeutic strategies

Summary: This 2026 review by Yao Chen, HuLi Li, and WenJie He systematically examines how mitochondrial dysfunction mediates inflammatory responses and impairs diabetic wound (DW) healing. Hyperglycemia induces excessive ROS production, mtDNA damage, and activation of pathways like NLRP3 inflammasome and cGAS-STING, leading to prolonged inflammation, reduced angiogenesis, and stalled repair. The article details mechanisms linking mitochondrial quality control failure to chronic non-healing ulcers and reviews emerging therapies: mitochondria-targeted antioxidants, nanomaterials, natural compounds, and strategies to restore bioenergetics and reduce oxidative stress. Highlights the need for translational approaches to address this core pathological driver in diabetic foot ulcers and other chronic wounds.

Key Highlights:

• Mitochondrial ROS and dysfunction central to prolonged inflammation in DFUs
• Key pathways: NLRP3, cGAS-STING, impaired angiogenesis/collagen deposition
• Therapeutic targets: Antioxidants, nanomaterials, natural mitochondrial modulators
• Authors: Yao Chen, HuLi Li, WenJie He

Read full review (open access)

Keywords: mitochondria diabetic wound, ROS inflammation, diabetic wound healing, Yao Chen

Diabetes-related Retinopathy, Foot Ulcers, and Other Lesions: A Photo Essay

Summary: This educational photo essay presents clinical images of diabetes-related complications, with a strong focus on foot ulcers alongside retinopathy and other lesions. Cases demonstrate neuropathic ulcers linked to structural deformities (hammer toes, Charcot neuroarthropathy), callus formation, and the need for debridement of necrotic, calloused, and fibrous tissue. It covers application of topical enzymes, special dressings, and offloading strategies. Visuals highlight progression risks and the importance of prompt multidisciplinary care involving podiatry, vascular assessment, and glycemic control to prevent amputation. Serves as a practical teaching resource for recognizing and managing diabetic foot disease in clinical settings.

Key Highlights:

• Visual cases of diabetic foot ulcers, Charcot foot, and related lesions
• Emphasis on debridement, dressings, and offloading techniques
• Links retinopathy and systemic complications to foot disease
• Relevance: Strong educational tool for diabetic wound recognition and management

View photo essay

Keywords: diabetic foot ulcers, photo essay, Charcot foot, debridement

Addressing Europe’s Acute Chronic Wound Crisis: A Call to Action

Summary: This joint industry white paper from the MedTech Europe Wound Care Sector Working Group (endorsed by multiple national associations and welcomed by Mölnlycke) addresses the growing burden of chronic wounds across Europe. It estimates 7.4–14.9 million people affected, with chronic wounds consuming up to 4% of healthcare budgets due to delayed diagnosis, prolonged treatment, preventable complications, and high recurrence rates. The report stresses under-recognition in policy and calls for coordinated action among policymakers, clinicians, payers, patient organizations, and industry. Key recommendations include making wound care a strategic health priority, strengthening education and workforce capacity, aligning reimbursement with value/outcomes, and accelerating innovation with real-world evidence. Aims to transform wound care into a more equitable, sustainable, and patient-centered system.

Key Highlights:

• Chronic wounds affect millions and strain EU healthcare budgets significantly
• Under-recognition leads to delayed care and poor outcomes
• Four priority actions: policy elevation, education, reimbursement reform, innovation scaling
• Collaborative call involving MedTech Europe and national associations

Read full article / White Paper summary

Keywords: chronic wound crisis, MedTech Europe, wound care policy, Europe wound care

Autologous Blood Clot Therapy for Wounds: Investigating the Chemotactic Effect on PBMCs and Fibroblasts in Diabetes

Summary: This in vitro study investigates the biological mechanism of topically applied autologous blood clot therapy (TABCT) for complex wounds. Researchers generated autologous clots ex vivo from 22 participants (12 controls, 10 with metabolic syndrome/type 2 diabetes – MetS/DM), cultured them for 24 hours, and analyzed the secretome for total protein, PDGF-BB, P-selectin, and CCL-5. They assessed effects on peripheral blood mononuclear cell (PBMC) chemotaxis and human dermal fibroblast migration using live-cell assays and scratch assays. MetS/DM-derived PBMCs showed heightened basal activation (increased ROS production, migration velocity, and sustained Ca²⁺ flux). Clots from MetS/DM patients released less total protein but higher P-selectin, indicating platelet hyperactivation. Despite containing measurable growth factors, the clot-derived secretome did not significantly enhance PBMC migration velocity or distance, though directionality modestly increased. Fibroblast wound closure remained limited (<30% across groups). Pretreatment with metformin, prednisone, or amoxicillin had negligible impact. The study concludes that TABCT’s clinical benefits are likely driven primarily by its fibrin scaffold properties rather than potent bioactive factor release for chemotaxis or fibroblast stimulation. Further mechanistic and translational research is needed.

Key Highlights:

• MetS/DM PBMCs exhibit heightened basal activation (↑ ROS, migration velocity, Ca²⁺ flux)
• Clot secretome shows limited enhancement of PBMC chemotaxis and fibroblast migration
• Higher P-selectin in MetS/DM clots indicates platelet hyperactivation
• Clinical benefits of TABCT likely due to fibrin scaffold, not growth factor release
• Authors: [Lead/corresponding authors not specified in abstract; full paper required for complete list]

Read full article (subscription/paywall may be required)

Keywords: autologous blood clot therapy, TABCT, diabetic wound healing, PBMC chemotaxis, fibrin scaffold

Development of a Novel Hydrogel Dressing Loaded with Curcumin and Aloe Vera for Diabetic Wound Healing

Summary: This 2026 study develops a novel hydrogel dressing incorporating curcumin and Aloe vera within a chitosan/gelatin matrix for diabetic wound healing. The formulation provides sustained release of bioactive compounds with antioxidant, anti-inflammatory, and antimicrobial properties. In STZ-induced diabetic rat models with full-thickness wounds, the hydrogel significantly accelerated wound closure, improved collagen deposition and organization, enhanced angiogenesis, and reduced oxidative stress and inflammation compared to controls. Demonstrates synergistic benefits of the natural compounds in a biocompatible delivery system. Supports further development as a promising, low-cost option for managing chronic diabetic foot ulcers.

Key Highlights:

• Curcumin + Aloe vera in chitosan/gelatin hydrogel
• Accelerated closure, better collagen, and angiogenesis in diabetic models
• Reduced oxidative stress and inflammation
• Relevance: Natural-functionalized hydrogel for hard-to-heal DFUs

Read full article (open access)

Keywords: curcumin hydrogel, Aloe vera, diabetic wound healing, natural hydrogel

Chronic Wounds in US: Challenges in Early Detection

Summary: This article addresses ongoing challenges in the early detection of chronic wounds across the United States. Despite advances in wound care, many patients experience delayed diagnosis due to limited access to specialists, low awareness, inconsistent screening protocols, and gaps in primary care training. Discusses the high burden of DFUs, pressure injuries, and venous ulcers, and the downstream consequences (infection, amputation, high costs). Calls for improved screening tools, patient education, telehealth integration, and adoption of innovative diagnostics (e.g., imaging, biomarkers) to enable earlier intervention and better outcomes.

Key Highlights:

• Major barriers to early chronic wound detection
• High clinical and economic burden of delayed diagnosis
• Need for better tools, education, and technology adoption
• Relevance: Underscores importance of prevention and early action

Read article

Keywords: chronic wounds, early detection, DFU screening, wound care challenges

SLWVS 2026

Summary: The Swiss Life & Wound Science Virtual Summit (SLWVS) 2026 is a virtual conference dedicated to advancements in life sciences and wound care. The event brings together clinicians, researchers, and industry experts to discuss cutting-edge innovations, evidence-based practices, and emerging therapies in wound management. Topics likely include advanced dressings, regenerative approaches, infection control, and multidisciplinary strategies for chronic and complex wounds. Offers accessible education for global participants without travel requirements.

Visit summit site

Keywords: SLWVS, wound care conference, virtual wound summit

The Diabetic Foot: Prevention is Paramount

Summary: This article emphasizes that prevention remains the most effective strategy for managing the diabetic foot. Highlights key preventive measures: regular risk screening (neuropathy, vascular status), patient education on daily foot inspection and self-care, appropriate offloading and therapeutic footwear, glycemic control, and early multidisciplinary intervention. Discusses the high personal and economic cost of DFUs and amputations, reinforcing that proactive care can dramatically reduce incidence and severity. Calls for heightened awareness among podiatrists and primary care providers to make prevention the default approach in diabetes management.

Key Highlights:

• Prevention as the primary goal in diabetic foot care
• Screening, education, offloading, and footwear as core strategies
• Multidisciplinary approach reduces DFU and amputation risk
• Relevance: Foundational message for all diabetic foot programs

Read article

Keywords: diabetic foot prevention, DFU prevention, offloading, patient education

Could a Simple Blood Test Signal Diabetic Foot Ulcer Risk?

Summary: February 2026 article discusses promising research into blood-based biomarkers that could help identify patients at high risk of developing diabetic foot ulcers (DFUs) before clinical signs appear. Explores how specific inflammatory, metabolic, or vascular markers in routine blood tests might predict ulcer formation or poor healing. Highlights the potential for simple, non-invasive screening to complement current tools (monofilament, ABI, temperature monitoring). Early detection could enable timely preventive interventions (offloading, education, vascular care) and reduce amputation rates. Calls for further validation and integration into routine diabetes care protocols.

Key Highlights:

• Blood biomarkers as potential early DFU risk indicators
• Complement to traditional clinical assessments
• Opportunity for proactive prevention and reduced amputations
• Relevance: Advances risk stratification in diabetic foot care

Read full article (subscription may be required)

Keywords: DFU risk biomarkers, blood test DFU, diabetic foot ulcer, prevention screening

Emerging Therapies, Innovations Highlight the Evolving Dermatology Treatment Landscape

Summary: This article reviews the rapidly evolving dermatology treatment landscape, highlighting new therapies and innovations with direct relevance to wound healing and chronic skin conditions. Covers advances in biologics, regenerative medicine, topical agents, and device-based technologies that improve outcomes for hard-to-heal wounds, ulcers, and inflammatory skin disorders. Emphasizes how these emerging tools are shifting care from reactive to proactive, with better healing rates, reduced scarring, and improved patient quality of life. Includes discussion on integration into clinical practice and future directions for dermatology-wound care collaboration.

Key Highlights:

• Focus on biologics and regenerative approaches for chronic wounds
• Innovations improving healing rates and reducing complications
• Shifting toward proactive, personalized dermatology care
• Relevance: Bridges dermatology and advanced wound management

Read full article

Keywords: dermatology innovations, regenerative medicine, chronic wound therapies